Archive for December, 2009

Case Western Reserve Alzheimer’s Disease Researcher Named 2009 AAAS Fellow 30 Dec 2009 on December 31st, 2009

Fat hormone linked to both cancer and Alzheimer’s on December 28th, 2009

Inverse Relationship Between Alzheimer’s Disease And Cancer on December 25th, 2009

Appetite-regulating hormone leptin linked to Alzheimer’s risk on December 22nd, 2009

NFL to encourage players to donate brains for study on December 20th, 2009

Alzheimer’s disease can now be detected many years before the presence of symptoms on December 18th, 2009

Hormone linked to appetite ‘could offer hope to prevent Alzheimer’s disease’ on December 16th, 2009

Elan Corporation PLC (ELN) and Transition Therapeutics Inc. (TTH.TO) Drop Top Drug Doses After Nine Alzheimer’s Patient Deaths on December 15th, 2009

Delayed ageing could protect from Alzheimer’s on December 14th, 2009

Potential New Target Found for Alzheimer’s Disease on December 11th, 2009

Recent Articles
Categories
Archives
- August 2010 (11)
- July 2010 (17)
- June 2010 (20)
- May 2010 (20)
- April 2010 (19)
- March 2010 (16)
- February 2010 (8)
- January 2010 (16)
- December 2009 (17)
- November 2009 (1)
Curaxis Pharmaceutical Corp.

Curaxis Pharmaceutical Corporation is a specialty company dedicated to finding cures for major age-related diseases with it initial focus is Alzheimer’s Disease (or AD). For more, visit www.curaxispharma.com
Follow Us On Twitter
- News:: New Study Explores Link Between Type 2 Diabetes, Alzheimer's http://bit.ly/bDgU67
- News:: Alzheimer's drug could put the brakes on deadly disease http://bit.ly/dgEAY0
- News:: New Alzheimer's test http://blog.curaxispharma.com/2010/08/17/new-alzheimers-test/

About

Curaxis Pharmaceutical Corporation is a specialty pharmaceutical company dedicated to finding cures for major age-related diseases. Our initial focus is Alzheimer’s Disease (or AD). Our lead product is a patented treatment that has shown the potential for treating and halting the progression of this devastating disease. Today, over 5,300,000 Americans suffer with Alzheimer’s Disease. It is estimated that more than $100 billion is spent annually in the United States to treat and care for those with this ailment. Sadly, these numbers are growing every day as the situation for many patients and their families grows desperate, despite the millions of dollars spent annually to find the answer to effectively treating this disease.

Copyright © 2010 Curaxis Pharmaceutical Corp.